NO20030474L - Legemiddel mot demens inneholdende 2-aryl-8- oksodihydropurinderivater som aktiv bestanddel - Google Patents
Legemiddel mot demens inneholdende 2-aryl-8- oksodihydropurinderivater som aktiv bestanddelInfo
- Publication number
- NO20030474L NO20030474L NO20030474A NO20030474A NO20030474L NO 20030474 L NO20030474 L NO 20030474L NO 20030474 A NO20030474 A NO 20030474A NO 20030474 A NO20030474 A NO 20030474A NO 20030474 L NO20030474 L NO 20030474L
- Authority
- NO
- Norway
- Prior art keywords
- aryl
- active ingredient
- drug containing
- dementia drug
- oxodihydropurine derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000230209 | 2000-07-31 | ||
| PCT/JP2001/006363 WO2002010167A1 (fr) | 2000-07-31 | 2001-07-24 | Medicaments contre la demence contenant des derives de 2-aryl-8-oxodihydropurine comme ingredient actif |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20030474D0 NO20030474D0 (no) | 2003-01-30 |
| NO20030474L true NO20030474L (no) | 2003-03-27 |
Family
ID=18723200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20030474A NO20030474L (no) | 2000-07-31 | 2003-01-30 | Legemiddel mot demens inneholdende 2-aryl-8- oksodihydropurinderivater som aktiv bestanddel |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6962921B2 (ru) |
| EP (1) | EP1306378A4 (ru) |
| KR (1) | KR100829297B1 (ru) |
| CN (1) | CN1247578C (ru) |
| AU (1) | AU7278701A (ru) |
| BR (1) | BR0112881A (ru) |
| CA (1) | CA2416706C (ru) |
| CZ (1) | CZ2003234A3 (ru) |
| HK (1) | HK1054231A1 (ru) |
| HU (1) | HUP0303714A3 (ru) |
| IL (1) | IL154049A0 (ru) |
| MX (1) | MXPA03000861A (ru) |
| NO (1) | NO20030474L (ru) |
| NZ (1) | NZ523812A (ru) |
| PL (1) | PL363870A1 (ru) |
| RU (1) | RU2277096C2 (ru) |
| SK (1) | SK1292003A3 (ru) |
| WO (1) | WO2002010167A1 (ru) |
| ZA (1) | ZA200300549B (ru) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7760101B2 (en) * | 2008-06-20 | 2010-07-20 | Kimberly-Clark Worldwide, Inc. | Method of reducing sensor corrosion in absorbent articles |
| EP2476682B1 (en) * | 2009-09-09 | 2017-04-26 | Sumitomo Dainippon Pharma Co., Ltd. | 8-oxodihydropurine derivative |
| US20140301947A1 (en) | 2011-06-06 | 2014-10-09 | Imperial Innovations Limited | Methods to predict binding affinity of tspo imaging agents to tspo |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5453428A (en) * | 1991-02-14 | 1995-09-26 | The Mount Sinai School Of Medicine Of The City Of New York | Method and composition for the treatment of apathy-amotivation syndrome |
| CA2112487C (en) * | 1991-06-26 | 2003-04-15 | James W. Young | Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron |
| US5212195A (en) * | 1992-05-13 | 1993-05-18 | Syntex (U.S.A.) Inc. | Substituted indole antagonists derivatives which are angiotensin II |
| NZ329798A (en) * | 1996-07-03 | 1999-04-29 | Japan Energy Corp | Purine derivatives their tautomers and salts thereof and interferon secretion inducers, antiviral agents and anticancer drugs containing the same |
| ZA9810490B (en) | 1997-12-03 | 1999-05-20 | Dainippon Pharmaceutical Co | 2-Aryl-8-oxodihydropurine derivative process for the preparation thereof pharmaceutical composition containing the same and intermediate therefor |
| JP3814125B2 (ja) * | 1999-06-02 | 2006-08-23 | 大日本住友製薬株式会社 | ２−アリール−８−オキソジヒドロプリン誘導体からなる医薬 |
-
2001
- 2001-07-24 PL PL01363870A patent/PL363870A1/xx not_active Application Discontinuation
- 2001-07-24 EP EP01951985A patent/EP1306378A4/en active Pending
- 2001-07-24 KR KR1020037001365A patent/KR100829297B1/ko not_active IP Right Cessation
- 2001-07-24 NZ NZ523812A patent/NZ523812A/en unknown
- 2001-07-24 WO PCT/JP2001/006363 patent/WO2002010167A1/ja active IP Right Grant
- 2001-07-24 US US10/343,453 patent/US6962921B2/en not_active Expired - Fee Related
- 2001-07-24 CZ CZ2003234A patent/CZ2003234A3/cs unknown
- 2001-07-24 CN CNB018163742A patent/CN1247578C/zh not_active Expired - Fee Related
- 2001-07-24 SK SK129-2003A patent/SK1292003A3/sk unknown
- 2001-07-24 HU HU0303714A patent/HUP0303714A3/hu unknown
- 2001-07-24 MX MXPA03000861A patent/MXPA03000861A/es active IP Right Grant
- 2001-07-24 IL IL15404901A patent/IL154049A0/xx unknown
- 2001-07-24 RU RU2003105827/04A patent/RU2277096C2/ru not_active IP Right Cessation
- 2001-07-24 BR BR0112881-7A patent/BR0112881A/pt not_active IP Right Cessation
- 2001-07-24 CA CA002416706A patent/CA2416706C/en not_active Expired - Fee Related
- 2001-07-24 AU AU7278701A patent/AU7278701A/xx not_active Withdrawn
-
2003
- 2003-01-21 ZA ZA200300549A patent/ZA200300549B/en unknown
- 2003-01-30 NO NO20030474A patent/NO20030474L/no not_active Application Discontinuation
- 2003-09-10 HK HK03106435.7A patent/HK1054231A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO20030474D0 (no) | 2003-01-30 |
| AU7278701A (en) | 2002-02-13 |
| KR20030019634A (ko) | 2003-03-06 |
| EP1306378A1 (en) | 2003-05-02 |
| CN1247578C (zh) | 2006-03-29 |
| CZ2003234A3 (cs) | 2003-05-14 |
| ZA200300549B (en) | 2003-08-19 |
| IL154049A0 (en) | 2003-07-31 |
| US6962921B2 (en) | 2005-11-08 |
| MXPA03000861A (es) | 2004-04-05 |
| CA2416706C (en) | 2009-04-07 |
| WO2002010167A1 (fr) | 2002-02-07 |
| EP1306378A4 (en) | 2005-02-09 |
| NZ523812A (en) | 2004-07-30 |
| HUP0303714A2 (hu) | 2004-03-01 |
| CN1466587A (zh) | 2004-01-07 |
| RU2277096C2 (ru) | 2006-05-27 |
| KR100829297B1 (ko) | 2008-05-13 |
| HUP0303714A3 (en) | 2007-03-28 |
| US20030166667A1 (en) | 2003-09-04 |
| PL363870A1 (en) | 2004-11-29 |
| SK1292003A3 (en) | 2003-08-05 |
| CA2416706A1 (en) | 2002-02-07 |
| BR0112881A (pt) | 2003-07-01 |
| HK1054231A1 (zh) | 2003-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DZ3227A1 (fr) | Compositions pharmaceutiques fournissant des concentrations de medicaments ameliorees | |
| ITTO20010008A0 (it) | Formulazione farmaceutica | |
| NO20043702L (no) | 8-azaprostaglandinderivatforbindelser og legemidler inneholdende forbindelsene som den aktive bestanddel | |
| FR2804025B1 (fr) | Compositions pharmaceutiques stabilisees | |
| NO20042807L (no) | Farmasoytiske sammensetninger som innbefatter aktive vitamin D forbindelser | |
| NO20030627L (no) | Hydrogel-drevet medikament doseringsform | |
| DK1498411T3 (da) | Diketohydrazinderivatforbindelser og medikamenter indeholdende forbindelserne som den aktive bestanddel | |
| EE05376B1 (et) | Vesisuspensioonip?hineÁparenteraalneÁravimpreparaatÁjaÁsedaÁsisaldavÁviaal | |
| NO20022970D0 (no) | Hydrogel-drevet medikamentdoseringsform | |
| NO20020976D0 (no) | Retarderte, orale, farmasöytiske administreringsformer | |
| EE200200097A (et) | Bensamiididerivaati sisaldav farmatseutiline preparaat | |
| NO20032438L (no) | Ortosubstituerte og metasubstituerte bisarylforbindelser, fremgangsmåte forfremstilling derav, deres anvendelse som et medikament samtfarmasöytiske preparater inneholdende forbindelsene | |
| NO20034149L (no) | Legemidler inneholdende triazaspiro[5.5]undekanderivater som den aktive bestanddel | |
| AT7729U3 (de) | Pharmazeutische zusammensetzungen enthaltend amlodipinmaleat | |
| ATE307571T1 (de) | Pharmazeutische formulierung enthaltend bicalutamid | |
| FIU20000164U0 (fi) | Uusi farmaseuttinen formulaatio | |
| NO20025635L (no) | Anvendelse av biguanidderivater til fremstilling av et legemiddel som har en sarhelende virkning | |
| NO20054214D0 (no) | Iminoeterderivatforbindelser og legemidler inneholdende forbindelsene som den aktive bestanddel | |
| DK1268419T3 (da) | Farmaceutisk aktive pyrrolidinderivater som BAX-inhibitorer | |
| NO20032614L (no) | Farmasöytisk sammensetning som har forbedret absorberbarhet | |
| DK1624869T3 (da) | Doseringsform indeholdende pantoprazol som aktiv bestanddel | |
| FR2802423B1 (fr) | Compositions pharmaceutiques | |
| IS2258B (is) | Setin tríasóló-pýridasín afleiða, lyfjasamsetningar gerðar úr henni | |
| DK1207881T3 (da) | Farmaceutisk middel omfattende et benzamidderivat som aktiv bestanddel | |
| AU2001277738A1 (en) | Piperidine derivatives and drugs containing these derivatives as the active ingredient |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |